Terns Pharmaceuticals, Inc. (TERN)
52.70
-0.01
(-0.02%)
USD |
NASDAQ |
Apr 16, 13:10
Terns Pharmaceuticals Research and Development Expense (Quarterly) : 18.90M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 2.499B |
| Corcept Therapeutics, Inc. | 64.86M |
| Cogent Biosciences, Inc. | 74.38M |
| BioMarin Pharmaceutical, Inc. | 192.41M |
| ADMA Biologics, Inc. | 1.376M |